Editorial: FDA should pull ineffective pregnancy drug Makena until we know it works
by The Times Editorial Board, Los Angeles Times
Feb 25, 2022
2 minutes
The U.S. Food and Drug Administration accelerated the approval of a drug called Makena meant to prevent premature births. Now there’s mounting evidence that the drug does not work. The FDA should use its authority to pull Makena from the market until and unless the company that makes it can prove that it is effective.
The drug’s approval was based on a
You’re reading a preview, subscribe to read more.
Start your free 30 days